Top o’ the morning to you, Data Sheet readers! Fortune senior editor Andrew Nusca here, filling in for Heather Clancy while she visits climes far warmer than the impending Snowpocalypse™ we’re expecting here at Fortune HQ. This morning: Samsung’s cash pile, a Maple Syrup Mafia (?!), and a damn good reason why Box’s IPO wasn’t […]

Bottom line: Apple found a way to sell more units at higher price points.

FDA will review application for alirocumab on a priority basis, targeting a decision by July 24.

Cities are looking to technology to save electricity used by street lights, monitor water mains and reduce crime. But is the cost worth it?

It’s another big week for earnings and football. Here’s what to watch for this week.

The photos so far are better than the videos.

Has a blow-out quarter already been baked in?

You don’t have to be a bomb thrower to be troubled by Apple’s compensation levels.